These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10953303)
1. Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Shao ZM; Shen ZZ; Fontana JA; Barsky SH Anticancer Res; 2000; 20(4):2409-16. PubMed ID: 10953303 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of anti-proliferation of curcumin on human breast cancer cells and its mechanism]. Di GH; Li HC; Shen ZZ; Shao ZM Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1764-8. PubMed ID: 14642080 [TBL] [Abstract][Full Text] [Related]
3. Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Shao ZM; Shen ZZ; Liu CH; Sartippour MR; Go VL; Heber D; Nguyen M Int J Cancer; 2002 Mar; 98(2):234-40. PubMed ID: 11857414 [TBL] [Abstract][Full Text] [Related]
4. Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines. Shao ZM; Wu J; Shen ZZ; Barsky SH Anticancer Res; 1998; 18(3A):1435-9. PubMed ID: 9673352 [TBL] [Abstract][Full Text] [Related]
5. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Shao ZM; Wu J; Shen ZZ; Barsky SH Cancer Res; 1998 Nov; 58(21):4851-7. PubMed ID: 9809990 [TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Maggiolini M; Bonofiglio D; Marsico S; Panno ML; Cenni B; Picard D; Andò S Mol Pharmacol; 2001 Sep; 60(3):595-602. PubMed ID: 11502892 [TBL] [Abstract][Full Text] [Related]
7. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Shao ZM; Alpaugh ML; Fontana JA; Barsky SH J Cell Biochem; 1998 Apr; 69(1):44-54. PubMed ID: 9513045 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells. Mitropoulou TN; Tzanakakis GN; Nikitovic D; Tsatsakis A; Karamanos NK Anticancer Res; 2002; 22(5):2841-6. PubMed ID: 12530007 [TBL] [Abstract][Full Text] [Related]
9. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093 [TBL] [Abstract][Full Text] [Related]
10. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro]. He FJ; Wang J; Niu JZ; Wang JF Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537 [TBL] [Abstract][Full Text] [Related]
11. Functional repression of estrogen receptor a by arsenic trioxide in human breast cancer cells. Chen GC; Guan LS; Hu WL; Wang ZY Anticancer Res; 2002; 22(2A):633-8. PubMed ID: 12014631 [TBL] [Abstract][Full Text] [Related]
12. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Hsieh CY; Santell RC; Haslam SZ; Helferich WG Cancer Res; 1998 Sep; 58(17):3833-8. PubMed ID: 9731492 [TBL] [Abstract][Full Text] [Related]
13. IGF-I affects glycosaminoglycan/proteoglycan synthesis in breast cancer cells through tyrosine kinase-dependent and -independent pathways. Mitropoulou TN; Theocharis AD; Nikitovic D; Karamanos NK; Tzanakakis GN Biochimie; 2004; 86(4-5):251-9. PubMed ID: 15194227 [TBL] [Abstract][Full Text] [Related]
14. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ; Jordan VC Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307 [TBL] [Abstract][Full Text] [Related]
16. [Genistein induced apoptosis in MCF-7 and T47D cells]. Yu Z; Zhang L; Wu D Wei Sheng Yan Jiu; 2003 Mar; 32(2):125-7. PubMed ID: 12793002 [TBL] [Abstract][Full Text] [Related]
17. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
18. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha. Gougelet A; Mueller SO; Korach KS; Renoir JM J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088 [TBL] [Abstract][Full Text] [Related]
19. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells. Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629 [TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines. Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]